Filed with ASX · · 4 pages · English
Curvebeam AI Ltd. has announced that its HiRise weight bearing CT system has received approval from China's National Medical Products Administration, marking a significant milestone for the company's expansion into the Chinese market. This approval allows CurveBeam to commence commercial sales in China and triggers a further equity investment milestone from its strategic partner. The company aims to leverage this opportunity for local manufacturing and supply chain optimization, enhancing its global commercial footprint. Next steps include progressing market launch activities and developing distribution channels for HiRise in China.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Corporate Office Level 10, 10 Queen Street Melbourne, Victoria, 3000, Australia +61 3 9620 0250 SEND US A MESSAGE Telephone: +61 3 9620 0250 Email: info@curvebeamai.com Website: curvebeamai.com Global Operations Headquarters 2800 Bronze Dr., Suite 110 Hatfield, PA 19440 USA ASX ANNOUNCEMENT ...
Follow Curvebeam AI into a list and get an email when it puts out news.
Follow Curvebeam AI